Arkolith/Insider Trading/VRTX/Form 4

McKechnie Duncan

EVP, Chief Commercial OfficerVERTEX PHARMACEUTICALS INC / MA (VRTX) · full profile →Form 4 · filed Feb 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.4M
Net Open-Market Flow
-$2.4M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 25, 2026Sell(S)2K$489.00$1.2M18K
Feb 25, 2026Sell(S)3K$486.35$1.2M20K
Feb 24, 2026Tax withholding(F)873$485.11$424K22K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000875320-26-000116) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML